DaVita logo

DaVita

Stock
Stock
ISIN: US23918K1088
Ticker: DVA
US23918K1088
DVA

Price

Price

CHART BY

Frequently asked questions

What is DaVita's market capitalization?

The market capitalization of DaVita is $13.94B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is DaVita's Price-to-Earnings (P/E) ratio?

The Price-to-Earnings (P/E) ratio (TTM) for DaVita is 18.32. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.

What is the Earnings Per Share (EPS) for DaVita?

DaVita's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $9.276. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for DaVita's stock?

Currently, 11 analysts cover DaVita's stock, with a consensus target price of $163.00. Analyst ratings provide insights into the stock's expected performance.

What is DaVita's revenue over the trailing twelve months?

Over the trailing twelve months, DaVita reported a revenue of $12.67B.

What is the EBITDA for DaVita?

DaVita's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $2.63B. EBITDA measures the company's overall financial performance.

What is the free cash flow of DaVita?

DaVita has a free cash flow of $1.42B. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

How many employees does DaVita have, and what sector and industry does it belong to?

DaVita employs approximately 70,000 people. It operates in the Health Care sector, specifically within the Medical/Nursing Services industry.

What is the free float of DaVita's shares?

The free float of DaVita is 78.32M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$13.94B
EPS (TTM) 
$9.276
Free Float 
78.32M
P/E ratio (TTM) 
18.32
Revenue (TTM) 
$12.67B
EBITDA (TTM) 
$2.63B
Free Cashflow (TTM) 
$1.42B

Pricing

1D span
$167.82$170.76
52W span
$103.56$170.29

Analyst Ratings

The price target is $163.00 and the stock is covered by 11 analysts.

Buy

1

Hold

8

Sell

2

Information

DaVita, Inc. engages in the provision of medical care services. It operates through the following two segments: US Dialysis and Related Lab Services, and Other-Ancillary Services and Strategic Initiatives. The US Dialysis and Related Lab Services segment offers kidney dialysis services in the United States for patients suffering from chronic kidney failure. The Other-Ancillary Services and Strategic Initiatives segment consist primarily of pharmacy services, disease management services, vascular access services, clinical research programs, physician services, direct primary care, end stage renal disease seamless care organizations, and comprehensive care. The company was founded in 1994 and is headquartered in Denver, CO.

Employees
70,000
Industries
Medical/Nursing Services
Sector
Health Care

Identifier

ISIN
US23918K1088
Primary Ticker
DVA

Knockouts

Join the conversation